Celera Genomics Company Profile

02:03 EDT 24th March 2018 | BioPortfolio

Celera is engaged principally in integrating high throughput technologies to create therapeutic discovery and development capabilities for internal use and for its customers and collaborators. Celera businesses are its online information business and its therapeutics discovery business. The online information business is a leading provider of genomic and related biological and medical information. Pharmaceutical, biotechnology, and academic customers use this information, along with customized information technology solutions provided by Celera, to enhance their capabilities in the fields of life science research and pharmaceutical and diagnostic discovery and development. Celera recently expanded its focus to include therapeutic discovery and development. Celera intends to leverage its capabilities in genomics, proteomics, and bioinformatics, both in internal programs and through collaborations, to identify drug targets and diagnostic markers, and to discover and develop novel therapeutic candidates. Initially, Celera intends to focus its therapeutic discovery efforts in the field of oncology. In June 2001, Celera announced the signing of a definitive merger agreement with Axys, a small molecule drug discovery and development company. Celera believes that Axys’ medicinal and structural chemistry and biology capabilities will accelerate the development of its therapeutic discovery business. Celera is also participating in the commercialization of diagnostic products based on its discoveries through Celera Diagnostics, a recently announced joint venture with Applied Biosystems.


45 West Gude Drive
United States of America


Phone: +1 240 453 3000
Fax: +1 240 453 4000

News Articles [292 Associated News Articles listed on BioPortfolio]

Berry Genomics Collaborates with 10X Genomics for Next-Gen Prenatal Tests

Berry Genomics of Beijing will collaborate with California's 10X Genomics to develop next-gen noninvasive prenatal tests (NIPT). Specifically, the companies will incorporate 10X's haplotype genomic in...

Genomics England announces appointment of global genomics pioneer as first CEO

Genomics England announces the appointment of its first Chief Executive Officer (CEO) today. Global genomics pioneer Professor John Mattick will join Genomics England in June. He will lead the organiz...

Rosetta Genomics Ltd.: Genoptix Completes Acquisition of PersonalizeDx from Rosetta Genomics

-First step in the process of Genoptix acquiring all of Rosetta Genomics -Next step is the completion of a merger for $8 million in cash pursuant to which value to Rosetta Genomics' equity holders...

Nebula wants to democratise genome sequencing, with the help of blockchain and cryptocurrency

A new start-up has been launched with a dazzling, technology-enabled vision of putting genomics into the hands of the DNA’s owners – individuals – rather than what it calls genomics ‘middle me...

Rosetta Genomics Ltd.: Genoptix to Acquire Rosetta Genomics for $10 Million in Cash

The value to Rosetta Genomics' equity holders is preliminarily estimated to be $0.60 per ordinary share, after deductions for debt, warrant termination payments, fees, expenses and other items CAR...

HL7 Meeting to Focus on Intersection of Clinical Genomics, AI

David RathsGrant Wood, a member of the HL7 Clinical Genomics Work Group and a senior strategist at Intermountain Healthcare’s Clinical Genetics Institute, talks about the confluence of genomics and ...

Financial Contrast: Rosetta Genomics (ROSG) and Its Peers

Rosetta Genomics is one of 186 public companies in the "Biotechnology & Medical Research" industry, but how does it contrast to its peers? We will compare Rosetta Genomics to similar companies bas...

Festival of Genomics London 2018: the landmark event making genomics mainstream

London, UK, 5th January 2018 / Sciad Newswire / This January sees the third edition of Festival of Genomics London, the largest meeting of its kind in the UK. Following two US editions of the event ...

Drugs and Medications [0 Results]


PubMed Articles [233 Associated PubMed Articles listed on BioPortfolio]

Genomics Education: Knowledge of Nurses Across the Profession and Integration Into Practice.

Since the completion of the Human Genome Project in 2003, the implications of genetics and genomics for health and illness have become clearer. All nurses, at all levels and across all specialties, mu...

Recent developments of software and database in microbial genomics and functional genomics.

Genetics and Genomics: An Oncology Nurse's Journey in Practice.

Cancer genetics and genomics are now an integral component of oncology care. Genetics and genomics guide recommendations not only for cancer prevention and early detection, but also for cancer treatme...

An Introduction to Integrative Genomics and Systems Medicine in Cancer.

In this Special Issue (SI), with a theme of "Integrative Genomics and Systems Medicine in Cancer", we have collected a total of 12 research and review articles from researchers in the field of genomic...

Synthetic genomics: the art of design and synthesis.

Benefited from the rapid development of high-throughput sequencing, genome editing, DNA synthesis and functional genomics, synthetic genomics gains the momentum in this century. The entire genomes of ...

Clinical Trials [78 Associated Clinical Trials listed on BioPortfolio]

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

This pilot clinical trial studies whether using high throughput drug sensitivity and genomics data is feasible in developing individualized treatment in patients with multiple myeloma or p...

Inflammatory Genomics in Human Carotid Artery Disease

To investigate the relationship between genetic variation in genes for inflammation and carotid artery atherosclerosis.

Companies [399 Associated Companies listed on BioPortfolio]

PE Corporation-Celera Genomics

The Celera Genomics Group is engaged principally in integrating advanced technologies to create therapeutic discovery and development capabilities for internal use and for its customers and collaborat...

Celera Genomics

Celera is engaged principally in integrating high throughput technologies to create therapeutic discovery and development capabilities for internal use and for its customers and collaborators. Celera ...

Celera Corporation

Celera is a healthcare business focusing on the integration of genetic testing into routine clinical care through a combination of products and services incorporating proprietary ...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

MetaMorphix, Inc.

MetaMorphix Inc. was formed in 1994 as a research collaboration between Genetics Institute, now a part of Wyeth (a pharmaceutical company) and the Johns Hopkins School of Medicine. The purpose of the ...

More Information about "Celera Genomics" on BioPortfolio

We have published hundreds of Celera Genomics news stories on BioPortfolio along with dozens of Celera Genomics Clinical Trials and PubMed Articles about Celera Genomics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celera Genomics Companies in our database. You can also find out about relevant Celera Genomics Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Corporate Database Quicklinks

Searches Linking to this Company Record